CooperCompanies Acquires Generate Life Sciences
November 10, 2021
CooperCompanies agreed to acquire Generate Life Sciences from GI Partners for approximately $1.6 billion. The deal expands CooperSurgical’s fertility, donor-gamete and newborn stem cell (cord blood & tissue) offerings; Generate reported roughly $250 million in trailing twelve-month revenue and will be integrated into CooperSurgical pending customary closing conditions.
- Buyers
- CooperCompanies
- Targets
- Generate Life Sciences
- Sellers
- GI Partners
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
LLR Partners Makes Growth Investment in Genesee Scientific
October 19, 2021
Medical Devices
LLR Partners completed a growth investment in Genesee Scientific, a San Diego–based manufacturer and distributor of life-science consumables and laboratory equipment. The partnership will fund expansion of Genesee's product portfolio and scaling of its national footprint; Audax Private Debt provided unitranche financing to support the transaction.
-
Generate Capital Acquires StormFisher Environmental Services and Launches Generate Upcycle
May 11, 2022
Environmental Services
Generate Capital, PBC launched a new circular-economy platform called Generate Upcycle and acquired Ontario-based StormFisher Environmental Services Ltd., integrating StormFisher's organics business and development team into the platform. The deal expands Generate's waste-to-value capabilities across anaerobic digestion, composting and biogas/RNG development to better serve municipalities, food processors and retailers in North America.
-
Trinity Life Sciences Acquires CBPartners
October 7, 2021
Healthcare Services
Trinity Life Sciences has acquired New York–headquartered CBPartners to significantly scale its Value, Access and Pricing business, adding over 75 dedicated experts and expanding Trinity's presence in New York City, San Francisco and London. The acquisition augments Trinity's market access, pricing and commercial strategy capabilities to better support life sciences companies in bringing products to market and ensuring patient access globally.
-
Discovery Life Sciences Acquires AllCells
July 12, 2022
Biotechnology
Discovery Life Sciences has acquired AllCells to create an integrated, end-to-end provider of clinical-grade and RUO primary cell products and analytic services for the cell and gene therapy (CGT) continuum. The combined business — operating as AllCells, a Discovery Life Sciences Company and led by AllCells CEO Danny Zheng — aims to expand GMP-compliant starting materials, donor programs and multi‑omic characterization to accelerate CGT discovery through commercialization.
-
GrowGeneration Acquires Assets of Canopy Crop Management
December 23, 2020
Agriculture
GrowGeneration Corp. acquired the assets and product portfolio (including the Power SI brand) of Southern California-based Canopy Crop Management. The acquisition brings founder Rex Gill and proprietary silicic acid formulations into GrowGen as the company pursues private label product development and expanded product offerings for its hydroponic retail chain.
-
Kennedy Lewis Acquires Remaining Stake in Generate Advisors (CLO Platform) from York Capital
September 30, 2025
Financial Services
Kennedy Lewis Investment Management acquired the remaining equity stake in CLO platform Generate Advisors from York Capital Management and will rebrand the business as Kennedy Lewis Loan Management. The move gives Kennedy Lewis full ownership of the platform (which manages more than $9 billion in CLO AUM) and positions the firm to scale its CLO and loan-management capabilities under Rizwan Akhter’s continued leadership.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.